'Very risky' for UK to delay second Covid vaccine dose: Biologics
Published Date: 1/7/2021
Source: CNBC International TV
Decisions related to health care policies and emergencies should be based on data, says Norman Baylor, president and CEO at Biologics Consulting Group.